RESUMO
The article presents a current view on the pathophysiology of acute coronary syndrome with and without ST elevation. Up-to-date thrombolytic agents and heparins are illustrated in the article. Current principles and thrombolytic therapy methods of an acute coronary syndrome without ST elevation are given in the article.
Assuntos
Fibrinolíticos/uso terapêutico , Isquemia Miocárdica/tratamento farmacológico , Doença Aguda , Coagulação Sanguínea/efeitos dos fármacos , Eletrocardiografia , Humanos , Isquemia Miocárdica/sangue , SíndromeRESUMO
Submitted in the paper are modern conceptions on etiology, pathophysiology, diagnosis and treatment of acute inflammatory rheumatism (IR). Some aspects of IR course in different age groups are highlighted, high informative value of new laboratory methods of diagnosis of its latent forms are validated. The place of interferons and selective inhibitors of COG-2 in the treatment of IR is determined.
Assuntos
Inibidores de Ciclo-Oxigenase/uso terapêutico , Interferon Tipo I/uso terapêutico , Febre Reumática , Adolescente , Adulto , Ciclo-Oxigenase 2 , Inibidores de Ciclo-Oxigenase 2 , Humanos , Isoenzimas/antagonistas & inibidores , Proteínas de Membrana , Prostaglandina-Endoperóxido Sintases , Proteínas Recombinantes , Febre Reumática/diagnóstico , Febre Reumática/tratamento farmacológico , Febre Reumática/etiologia , Cardiopatia Reumática/diagnóstico , Cardiopatia Reumática/tratamento farmacológico , Cardiopatia Reumática/etiologiaRESUMO
Results are analysed of the efficiency of complex treatment of patients with chronic cor pulmonale including cardiac glycosides, agents stimulating metabolism processes in the myocardium, immunoactive drugs and antiaggregants. The efficacy was evaluated of cardiotonic therapy with different glycosides in hospital and outpatient treatment. The necessity is substantiated of including into complex treatment drugs of metabolic action, immunoactive and antiaggregant agents with the purpose of reducing the threshold of sensitivity of the myocardium to the toxic effect of cardiac glycosides.
Assuntos
Doença Cardiopulmonar/tratamento farmacológico , Doença Crônica , Quimioterapia Combinada , Humanos , Doença Cardiopulmonar/imunologia , Doença Cardiopulmonar/metabolismoRESUMO
The authors examined 35 patients suffering from ischemic heart disease with signs of stage-I circulatory insufficiency. It was established that the hemorheological values were distinctly increased. This increase was associated with an increase of the general peripheral resistance.